Abstract
Background
Many patients with hepatocellular carcinoma (HCC) never receive cancer-directed therapy. In order to tailor interventions to increase access to appropriate therapy, we sought to understand the barriers and facilitators to HCC care.
Methods
Patients with recently diagnosed HCC were identified through the University of North Carolina (UNC) HCC clinic or local hospital cancer registrars (rapid case ascertainment, RCA). Two qualitative researchers conducted in-depth, semi-structured interviews. Interviews were audiotaped, transcribed, and coded.
Results
Nineteen interviews were conducted (10 UNC, 9 RCA). Key facilitators of care were: physician knowledge; effective communication regarding test results, plan of care, and prognosis; social support; and financial support. Barriers included: lack of transportation; cost of care; provider lack of knowledge about HCC; delays in scheduling; or poor communication with the medical team. Participants suggested better coordination of appointments and having a primary contact within the healthcare team.
Limitations
We primarily captured the perspectives of those HCC patients who, despite the challenges they describe, were ultimately able to receive HCC care.
Conclusions
This study identifies key facilitators and barriers to accessing care for HCC in North Carolina. Use of the RCA system to identify patients from a variety of settings, treated and untreated, enabled us to capture a broad range of perspectives. Reducing barriers through improving communication and care coordination, assisting with out-of-pocket costs, and engaging caregivers and other medical providers may improve access. This study should serve as the basis for tailored interventions aimed at improving access to appropriate, life-prolonging care for patients with HCC.
Funder
Agency for Healthcare Research and Quality
Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill
Publisher
Public Library of Science (PLoS)
Reference47 articles.
1. Centers for Disease Control and Prevention, National Center for Health Statistics. NationalHealth and Nutrition Examination Survey–Viral Health: Department of Healthand Human Services.
2. AASLD guidelines for the treatment of hepatocellular carcinoma;JK Heimbach;Hepatology,2018
3. Population attributable fractions of risk factors for hepatocellular carcinoma in the United States;OV Makarova-Rusher;Cancer,2016
4. Hepatocellular carcinoma.;A Forner;Lancet,2012
5. Comparison of hepatocellular carcinoma in Eastern versus Western populations;SP Choo;Cancer,2016
Cited by
3 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献